Simplex Trading’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-108
Closed -$11K 9762
2023
Q1
$11K Buy
+108
New +$20.4K ﹤0.01% 7477
2022
Q4
Sell
-4
Closed -$2K 10196
2022
Q3
$2K Sell
4
-1
-20% -$871 ﹤0.01% 9339
2022
Q2
$3K Sell
5
-4
-44% -$5.49K ﹤0.01% 9191
2022
Q1
$22K Sell
9
-41
-82% -$97.2K ﹤0.01% 8156
2021
Q4
$129K Buy
50
+35
+233% +$140K ﹤0.01% 5849
2021
Q3
$106K Hold
15
﹤0.01% 6538
2021
Q2
$103K Buy
+15
New +$104K ﹤0.01% 6691
2021
Q1
Hold
0
5545
2020
Q3
Hold
0
-$10K 8373
2020
Q2
Hold
0
6656
2020
Q1
Hold
0
6094
2019
Q4
Hold
0
5523
2019
Q3
Hold
0
5058
2019
Q2
Hold
0
-$14K 7655
2019
Q1
Hold
0
5948

Other funds holding RDHL

Simplex Trading's RDHL Position: Q1 2023 in Review

Simplex Trading sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 8 shares — an estimated $1.51K sold.

Simplex Trading first reported a position in RDHL in Q4 2019 and held it in 12 quarters. The position peaked at $224K in Q2 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Simplex Trading reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 8 Redhill Biopharma shares in Q1 2023, an estimated $1.51K.
  • Simplex Trading first reported a position in Redhill Biopharma in Q4 2019 and held it in 12 quarters.
  • Simplex Trading's Redhill Biopharma position peaked at $224K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.